Showing results (31-40 of 58) with videos related to
Sort By:
Pageof 6
JACC. Cardiovascular Interventions|August 23, 2014
Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trialSammy Elmariah, Anthony J Furlan, Mark Reisman, et al.Journal of Neurosurgery|September 27, 2014
Early reperfusion and clinical outcomes in patients with M2 occlusion: pooled analysis of the PROACT II, IMS, and IMS II studiesRalph Rahme, Sharon D Yeatts, Todd A Abruzzo, et al.The New England Journal of Medicine|March 16, 2012
Closure or medical therapy for cryptogenic stroke with patent foramen ovaleAnthony J Furlan, Mark Reisman, Joseph Massaro, et al.Stroke|November 6, 2010
Study design of the CLOSURE I Trial: a prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the STARFlex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovaleAnthony J Furlan, Mark Reisman, Joseph Massaro, et al.Stroke|September 14, 2020
Risk of Paradoxical Embolism (RoPE)-Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure: An Analysis of 3 TrialsDavid M Kent, Jeffrey L Saver, Robin Ruthazer, et al.Stroke|June 8, 2002
Computed tomographic findings in patients undergoing intra-arterial thrombolysis for acute ischemic stroke due to middle cerebral artery occlusion: results from the PROACT II trialHeidi C Roberts, William P Dillon, Anthony J Furlan, et al.Journal of the American College of Cardiology|February 27, 2016
Device Closure of Patent Foramen Ovale After Stroke: Pooled Analysis of Completed Randomized TrialsDavid M Kent, Issa J Dahabreh, Robin Ruthazer, et al.Stroke|September 29, 2017
Baseline Quality of Life and Risk of Stroke in the ALLHAT Study (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)Tanzila Shams, Alexander P Auchus, Suzanne Oparil, et al.European Heart Journal|July 5, 2015
Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysisDavid M Kent, Issa J Dahabreh, Robin Ruthazer, et al.Stroke|August 5, 2006
Sex-based differences in the effect of intra-arterial treatment of stroke: analysis of the PROACT-2 studyMichael D Hill, David M Kent, Judith Hinchey, et al.Pageof 6